As the U.S. celebrated another Constitution Day on Sept. 17, Frank Donatelli, McGuireWoods Consulting executive vice president and director, reflected on a speech given by President Ronald Reagan 31 years ago, on the 200th anniversary of the ratification of the Constitution.
Robert Wasinger, senior vice president on McGuireWoods Consulting’s federal public affairs team, was quoted in a Sept. 17 cover story by CQ Magazine.
Was Policy Fellow for House Oversight and Government Reform Committee
Greg Walden, partner at McGuireWoods and senior advisor with McGuireWoods Consulting, recently discussed legal concerns, ethical considerations and policy around autonomous vehicles with the Corporate Counsel Business Journal.
In a Sept. 10 opinion piece for The Hill, McGuireWoods Consulting executive vice president and director, Frank Donatelli, compares the upcoming midterm elections and modern politics to a heavyweight fight.
This Week: More rules to OMB…House overhauls OTC drug rules…HELP Committee looks at drug costs…FDA outlines reorganization
Your weekly North Carolina political news report.
Final day for early voting - what you should know
Word of the Week: Bureaucracy
The OMB and Treasury issued a memorandum of agreement (MOA) in April that established a new interagency process for reviewing certain tax regulations, namely those stemming from the 2017 GOP tax law. And things are working as expected…
This Week: Ways and Means marks up HSA and other insurance-related legislation, CMS releases several payment rules … 340B discussed again … VA secretary nominee moves to the full Senate.
An overview of the upcoming week in Congress from the McGuireWoods Consulting Federal Public Affairs Team.
The House Ways and Means Committee passed several measures to expand tax-advantaged health savings accounts (HSA).
An overview of the upcoming week in Congress from the McGuireWoods Consulting Tax Policy Update Team.
On June 22, the House of Representatives concluded two weeks of voting on opioid legislation by approving a package that combines dozens of individual opioid-related bills that the House had approved over the past two weeks.